|
A Companhia de Seguros Populares da China Limited (1339.HK) Avaliação DCF |
Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
Design Profissional: Modelos Confiáveis E Padrão Da Indústria
Pré-Construídos Para Uso Rápido E Eficiente
Compatível com MAC/PC, totalmente desbloqueado
Não É Necessária Experiência; Fácil De Seguir
The People's Insurance Company (Group) of China Limited (1339.HK) Bundle
Aprimore suas estratégias de investimento com a Companhia de Seguros Populares (Grupo) da China Limited (1339HK) DCF Calculator! Utilize dados financeiros autênticos, ajuste as projeções e despesas de crescimento e observe instantaneamente como essas modificações afetam o valor intrínseco de (1339HK).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 633,695.5 | 647,081.6 | 671,811.1 | 548,428.2 | 600,238.3 | 595,759.6 | 591,314.3 | 586,902.2 | 582,523.0 | 578,176.5 |
| Revenue Growth, % | 0 | 2.11 | 3.82 | -18.37 | 9.45 | -0.74615 | -0.74615 | -0.74615 | -0.74615 | -0.74615 |
| EBITDA | 45,631.2 | 50,173.8 | 46,845.6 | 46,980.0 | 84,684.7 | 53,144.7 | 52,748.2 | 52,354.6 | 51,964.0 | 51,576.2 |
| EBITDA, % | 7.2 | 7.75 | 6.97 | 8.57 | 14.11 | 8.92 | 8.92 | 8.92 | 8.92 | 8.92 |
| Depreciation | 4,862.8 | 5,209.3 | 5,674.9 | 5,564.5 | 5,466.2 | 5,174.1 | 5,135.5 | 5,097.2 | 5,059.1 | 5,021.4 |
| Depreciation, % | 0.76738 | 0.80505 | 0.84472 | 1.01 | 0.91067 | 0.86849 | 0.86849 | 0.86849 | 0.86849 | 0.86849 |
| EBIT | 40,768.4 | 44,964.5 | 41,170.6 | 41,415.5 | 79,218.5 | 47,970.6 | 47,612.7 | 47,257.4 | 46,904.8 | 46,554.8 |
| EBIT, % | 6.43 | 6.95 | 6.13 | 7.55 | 13.2 | 8.05 | 8.05 | 8.05 | 8.05 | 8.05 |
| Total Cash | 25,279.3 | 23,812.4 | 23,352.3 | 23,904.3 | 726,047.7 | 137,625.1 | 136,598.2 | 135,578.9 | 134,567.3 | 133,563.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | 12,442.9 | 2,470.0 | 2,451.6 | 2,433.3 | 2,415.1 | 2,397.1 |
| Account Receivables, % | 0 | 0 | 0 | 0 | 2.07 | 0.4146 | 0.4146 | 0.4146 | 0.4146 | 0.4146 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | 55,225.7 | 6,656.5 | 8,338.6 | 8,727.7 | 5,305.5 | 16,037.9 | 15,918.3 | 15,799.5 | 15,681.6 | 15,564.6 |
| Accounts Payable, % | 8.71 | 1.03 | 1.24 | 1.59 | 0.8839 | 2.69 | 2.69 | 2.69 | 2.69 | 2.69 |
| Capital Expenditure | 30,565.1 | 41,113.8 | -7,187.7 | -3,905.3 | -4,806.0 | -3,077.3 | -3,054.3 | -3,031.6 | -3,008.9 | -2,986.5 |
| Capital Expenditure, % | 4.82 | 6.35 | -1.07 | -0.7121 | -0.80068 | -0.51653 | -0.51653 | -0.51653 | -0.51653 | -0.51653 |
| Tax Rate, % | 39.29 | 39.29 | 39.29 | 39.29 | 39.29 | 39.29 | 39.29 | 39.29 | 39.29 | 39.29 |
| EBITAT | 36,413.0 | 38,370.6 | 34,453.6 | 27,393.4 | 48,090.0 | 36,955.2 | 36,679.4 | 36,405.7 | 36,134.1 | 35,864.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 127,066.6 | 36,124.4 | 34,623.0 | 29,441.7 | 32,885.0 | 59,757.3 | 38,659.3 | 38,370.9 | 38,084.6 | 37,800.4 |
| WACC, % | 6.19 | 6.15 | 6.13 | 5.96 | 5.9 | 6.07 | 6.07 | 6.07 | 6.07 | 6.07 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 181,115.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 38,556 | |||||||||
| Terminal Value | 948,491 | |||||||||
| Present Terminal Value | 706,598 | |||||||||
| Enterprise Value | 887,713 | |||||||||
| Net Debt | 30,277 | |||||||||
| Equity Value | 857,436 | |||||||||
| Diluted Shares Outstanding, MM | 44,402 | |||||||||
| Equity Value Per Share | 19.31 |
Benefits You'll Receive
- Genuine Financial Data: Comprehensive preloaded financials – encompassing revenue to EBIT – derived from actual and forecasted figures for The People's Insurance Company (Group) of China Limited (1339HK).
- Complete Customization: Modify all essential parameters (highlighted cells) such as WACC, growth rates, and tax percentages.
- Immediate Valuation Refresh: Automatic updates to reassess how changes affect the fair value of The People's Insurance Company (Group) of China Limited (1339HK).
- User-Friendly Excel Template: Designed for easy adjustments, scenario analysis, and in-depth projections.
- Efficient and Precise: Eliminate the need to create models from the ground up while ensuring accuracy and adaptability.
Key Features
- Customizable Insurance Parameters: Adjust essential metrics such as premium growth, claims ratio, and reserve levels.
- Instant Risk Assessment: Provides real-time evaluations of policy performance and risk exposure.
- High-Precision Modeling: Incorporates The People's Insurance Company's (Group) of China Limited (1339HK) actual financial data for accurate projections.
- Effortless Scenario Testing: Easily explore various underwriting assumptions and assess their impacts.
- Efficiency Booster: Streamlines the process, removing the necessity for developing intricate insurance models from the ground up.
How It Works
- Step 1: Download the Excel file.
- Step 2: Examine the pre-filled data for The People's Insurance Company (Group) of China Limited (1339HK) (historical and projected).
- Step 3: Modify key assumptions (yellow cells) according to your analysis.
- Step 4: Observe automatic recalculations for the intrinsic value of The People's Insurance Company (Group) of China Limited (1339HK).
- Step 5: Utilize the results for investment strategies or financial reporting.
Why Choose The People's Insurance Company (Group) of China Limited (1339HK)?
- Save Time: Instantly access comprehensive insurance solutions without the hassle of lengthy processes.
- Enhance Reliability: Our robust data and analytics minimize errors, ensuring accurate coverage assessment.
- Fully Customizable: Adjust policies to meet your specific needs and preferences seamlessly.
- User-Friendly Interface: Intuitive design and clear explanations make understanding your options effortless.
- Endorsed by Industry Leaders: Trusted by professionals who prioritize quality and effectiveness.
Who Could Benefit from This Product?
- Investors: Effectively assess the fair value of The People's Insurance Company (Group) of China Limited (1339HK) prior to making investment choices.
- CFOs: Utilize a high-quality DCF model for comprehensive financial reporting and analysis.
- Consultants: Swiftly customize the template for client valuation reports.
- Entrepreneurs: Acquire insights into the financial modeling practices employed by major corporations.
- Educators: Implement this as a resource to illustrate various valuation methodologies.
Contents of the Template
- Historical Data: Features The People's Insurance Company (Group) of China Limited's past financial performance and foundational forecasts.
- DCF and Levered DCF Models: Comprehensive templates designed to assess the intrinsic value of The People's Insurance Company (Group) of China Limited.
- WACC Sheet: Pre-configured calculations for the Weighted Average Cost of Capital.
- Editable Inputs: Adjust crucial variables such as growth rates, EBITDA percentages, and CAPEX assumptions.
- Quarterly and Annual Statements: A thorough analysis of The People's Insurance Company (Group) of China Limited's financials.
- Interactive Dashboard: Dynamically visualize valuation outcomes and future projections.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.